| Lapatinib plus capecitabine in treating HER2-positive advanced breast cancer: efficacy, safety, and biomarker results from Chinese patients | |
| Xu Bing-He; Jiang Ze-Fei; Chua Daniel; Shao Zhi-Min; Luo Rong-Cheng; Wang Xiao-Jia; Liu Dong-Geng; Yeo Winnie; Yu Shi-Ying; Newstat Beth | |
| 2011 | |
| 卷号 | 30期号:5页码:327-35 |
| 关键词 | Lapatinib capecitabine HER2 metastatic breast cancer |
| ISSN号 | 1000-467X |
| URL标识 | 查看原文 |
| 收录类别 | PUBMED ; CSCD |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/6726149 |
| 专题 | 中国医学科学院 北京协和医学院 |
| 推荐引用方式 GB/T 7714 | Xu Bing-He,Jiang Ze-Fei,Chua Daniel,et al. Lapatinib plus capecitabine in treating HER2-positive advanced breast cancer: efficacy, safety, and biomarker results from Chinese patients[J],2011,30(5):327-35. |
| APA | Xu Bing-He.,Jiang Ze-Fei.,Chua Daniel.,Shao Zhi-Min.,Luo Rong-Cheng.,...&Wang Li.(2011).Lapatinib plus capecitabine in treating HER2-positive advanced breast cancer: efficacy, safety, and biomarker results from Chinese patients.,30(5),327-35. |
| MLA | Xu Bing-He,et al."Lapatinib plus capecitabine in treating HER2-positive advanced breast cancer: efficacy, safety, and biomarker results from Chinese patients".30.5(2011):327-35. |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论